Home Your basket
• Sinonasal malignant melan...
   Price 5.50 €
• Middle ear overpressure w...
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• Chronic laryngitis...
   Price 8.50 €
• Non-traumatic nasal septa...
   Price 8.50 €
• Otologic surgery in HIV-i...
   Price 8.50 €
• An original case of laryn...
   Price 8.50 €
• Management of free-flap f...
   Price 14.00 €
• Cochlear implantation in ...
   Price 10.50 €
• Autologous cartilaginous ...
   Price 10.50 €
• Prosodic analysis of spee...
   Price 10.50 €
• Perceptual assessment of ...
   Price 10.50 €
• Acoustic recognition of e...
   Price 8.50 €
• Resorption of cartilage g...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• The frontal pneumosinus d...
   Price 8.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Research in cancer : adva...
   Price 5.50 €
• Actinomycosis of the midd...
   Price 5.50 €
• "Sonorous man" - an appro...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Comparative study using A...
   Price 10.50 €
• Modern lipostructure: The...
   Price 10.50 €
• Description of complicati...
   Price 5.50 €
• Diagnosis and treatment o...
   Price 8.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Clinico-radiological cons...
   Price 10.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• Cochlear implantation in ...
   Price 14.00 €
• Modified butterfly cartil...
   Price 10.50 €
• Free sorting task of spee...
   Price 10.50 €
• Facial nerve monitoring d...
   Price 12.50 €
• The nasal framework in rh...
   Price 10.50 €
• Solitary myofibroma of th...
   Price 5.50 €
• Multiple intracranial epi...
   Price 14.00 €
• The value of the operatin...
   Price 10.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Vascular tumors of the n...
   Price 10.50 €
• Cosmetic radiofrequency...
   Price 10.50 €

Total Order 390.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE